• Leidos received a $317.9 million sole-source bridge contract from DHA.
• The contract supports MHS GENESIS electronic health record platform.
• Work will be performed in Reston, Virginia, through January 2028.
• Contract scope decreases over 12 months as DHA shifts work to other contractors.

This contract award may indicate DHA's continued reliance on Leidos for MHS GENESIS support, which could strengthen the company's position in the federal health IT market. The shift towards a modular acquisition model suggests DHA may be seeking more direct relationships with solution providers, which could impact the competitive landscape for future contracts.